RXMD:OTO-Progressive Care Inc (USD)

COMMON STOCK | Pharmaceutical Retailers | OTC Pink

Last Closing

USD 1.98

Change

0.00 (0.00)%

Market Cap

USD 3.46M

Volume

4.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Progressive Care Inc provides prescription pharmaceuticals specializing in health practice risk management, compounded medications, sale of anti-retroviral medications, medication therapy management & supply of prescription medications to facilities.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-16 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
ALBHF Alibaba Health Information Tec..

N/A

USD 7.22B
RADLY Raia Drogasil SA ADR

N/A

USD 6.95B
CLCGY Clicks Group Ltd

+0.52 (+1.39%)

USD 3.99B
SAEYY Shop Apotheke Europe N.V

+0.86 (+7.60%)

USD 2.48B
SHPPF Shop Apotheke Europe N.V

N/A

USD 2.28B
ZRSEF Zur Rose Group AG

N/A

USD 1.12B
NVACF Nova Cannabis Inc

-0.03 (-2.85%)

USD 0.05B
NOTR Nowtransit Inc

N/A

USD 0.04B
RADCQ Rite Aid Corporation

+0.02 (+113.33%)

USD 0.01B
HEWA Healthwarehouse.Com

N/A

USD 6.97M

ETFs Containing RXMD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -36.94% 33% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.94% 33% F 16% F
Trailing 12 Months  
Capital Gain -56.00% 38% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -56.00% 38% F 19% F
Trailing 5 Years  
Capital Gain -85.18% 60% D- 23% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -85.18% 60% D- 22% F
Average Annual (5 Year Horizon)  
Capital Gain 27.41% 60% D- 70% C-
Dividend Return 27.41% 60% D- 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 587.18% 28% F 13% F
Risk Adjusted Return 4.67% 44% F 39% F
Market Capitalization 3.46M 65% D 38% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.